stocks logo

IQV Earning Date, Transcript Summary & Report

IQVIA Holdings Inc
$
167.690
-6.680(-3.830%)

IQV Earnings Prediction

The chart below shows how IQV performed 10 days before and after its earnings report, based on data from the past quarters. Typically, IQV sees a -1.55% change in stock price 10 days leading up to the earnings, and a +1.42% change 10 days following the report. On the earnings day itself, the stock moves by +1.38%. This data can give you a slight idea of what to expect for the next quarter's release.

IQV Key Earning Data

2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
3.96B
2.33%
1.59%
Gross Margin
27.16%
-2.20%
-3.79%
Operating Margin
15.72%
17.40%
5.93%
Net Margin
11.04%
-8.99%
50.82%
EPS
2.42
-4.72%
56.13%
No Data Available

IQV Earnings Analysis

IQVIA Holdings Inc Corporation (IQV.N) Earnings Conference Call

Positive

  • Strong Revenue Growth: Revenue growth of 5.5% at constant currency for the full year 2024, excluding COVID-related work, demonstrating strong operational performance.

  • Adjusted EBITDA Growth: Adjusted EBITDA increased by 3.1% in Q4, contributing to a full year adjusted EBITDA growth of 3.2%, reflecting effective cost management and revenue growth.

  • Record Free Cash Flow: Free cash flow reached a record $721 million in Q4, contributing to a total of $2.1 billion for the full year, marking a 41% increase year-over-year.

  • Strong Q4 Net New Bookings: Net new bookings for Q4 exceeded $2.5 billion, highlighting the successful efforts of the RMBS team in securing new business contracts despite a challenging environment.

  • Backlog Growth and Demand: The backlog at year-end stood at $31.1 billion, representing a 5.5% increase year-over-year at constant currency, indicating strong demand and future revenue visibility.

Negative

  • Quarterly Revenue Growth Slowdown: Revenue for the fourth quarter grew only 2.3% on a reported basis and 3% at constant currency, indicating a slowdown in growth compared to previous periods.

  • R&D Revenue Decline: R&D Solutions revenue for the fourth quarter declined by 1.3% reported and 1% at constant currency, highlighting challenges in this segment.

  • Revenue Decline in Medical Solutions: Contract Sales and Medical Solutions revenue decreased by 4.8% reported and 3.2% at constant currency, reflecting ongoing difficulties in this area.

  • Increased Cancellations and Volatility: Cancellations in 2024 were nearly 50% higher than the average of the previous three years, indicating increased volatility and uncertainty in client spending.

  • Bookings Performance Analysis: Gross new bookings before cancellations were up mid single digits, but the elevated cancellations led to a challenging net bookings environment.

Key Financial Performance iconKey Financial Performance
Operating Highlights iconOperating Highlights
Risks or Challenges iconRisks or Challenges
Strategic Initiatives & Outlook iconStrategic Initiatives & Outlook
Shareholder Return Plan iconShareholder Return Plan

IQV FAQs

How does IQV typically perform around its earnings report dates?

IQV's stock performance around earnings reports can vary, but historical data shows specific patterns, such as a -1.55% change leading up to the report and a +1.42% change in the 10 days following the release.

Is IQVIA Holdings Inc (IQV) Q4 2024 Earnings Call Summary positive or negative?

How can historical earnings data help predict future stock performance?

IQV Earnings Deck

Earnings call transcript: IQVIA Q4 2024 beats expectations, stock rises

IQV Earning Call Sentiment

Earnings call transcript: IQVIA Q4 2024 beats expectations, stock rises

stocks logo

IQV.N

-3.83%
Positive
The earnings call presents mixed signals. Financial performance shows growth, with revenue and EPS increasing, and a strong share repurchase program suggests confidence. However, the Q&A section reveals concerns over cancellations and competitive pricing. While the backlog and pipeline are strong, the uncertain operating environment and vague management responses create uncertainty. The positive aspects are balanced by potential risks, leading to a neutral sentiment. Given the lack of market cap data, assuming a moderate market reaction, the stock price is likely to remain relatively stable in the short term.